- 02:00 PM Voltamp Transformers surges 7.3%
- 01:58 PM Hold Hindalco Industries: Satish Betadpur
- 01:55 PM Buy GMR Infra; target of Rs 95: Anand Rathi
- 01:53 PM ITC can test Rs 275-280: Satish Betadpur
- 01:52 PM Sensex has resistance at 17202: Geojit BNP
- 01:48 PM Hold Unitech, says Hemen Kapadia
- 01:44 PM Sun TV to raise advertisement rates, stock up
- 01:32 PM Sensex trades lower on weak European cues; heavywe...
- 01:28 PM Bajaj Hindusthan makes a sweet gain
- 01:07 PM Hold Mphasis, target of Rs 650: Emkay Global
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted tentative approval for the Company’s Abbreviated New Drug Application (ANDA) for its generic version of Eli Lilly and Co’s Gemzar®, gemcitabine injection.
These generic gemcitabine injections are therapeutic equivalents of Eli Lilly and Co’s Gemzar® injections available in two strengths: 200 mg and 1 g single use vial. These strengths of gemcitabine injections have annual sales of approximately USD 680 million in the US.
Gemcitabine is an anticancer, used singly or in combination with other anticancer agents.
Sourced from: Sun Pharmaceutical Industries Ltd
|
|
Business
Business News | Economy | Earnings | BSE NSE Notices
General News
Current Affairs | Politics | World News | Sports | Entertainment
Corporate Strategy
Management | Advertising | Marketing | Legal
Personal Finance
Tax | Insurance | Credit Cards | Loans | Property | Retirement | Investment Help | Financial Planning | Fixed Income
Markets
Local Market | Global Market | Market Cues | Analysis | Expert & FII outlook | Brokerage Recomendation
Stocks
Stocks in News | Expert Advice | ADRs & GDRs | IPO
Mutual Funds
News | Advice | MF Analysis | Fund Managers Views
Lifestyle
Travel | Wellness | Technology | Auto| Books
-
Most Read
-
Most Viewed
- 10 Companies that FIIs love
- Ganeshaspeaks: Market prediction for Nov 24
- Mitesh Thacker's top 5 picks for trade today
- 10 companies that MF managers love
- Trading in MF units to start in 15 days: SEBI
- Den Networks slips 22% after listing at Rs 195
- Experts see mkts at new highs, advise sectors
- Corrections in '10 to be more aggressive, violent: JPMorgan
- Hold Unitech, says Hemen Kapadia
Source: CNBC-TV18
- Sun TV to raise advertisement rates, stock up
Source: Moneycontrol.com
- Sensex trades lower on weak European cues; heavyweights dip
Source: Moneycontrol.com
- Bajaj Hindusthan makes a sweet gain
Source: Moneycontrol.com
- Mahindra may increase car prices due to rising input costs
Source: Business Line
- Renault to continue with M&M for Logan, says Ghosn
Source: Business Line
- Market volatility poses valuation problems: IRDA
Source: Business Line
- Punjab, Haryana buck all-India rice decline trend
Source: Business Line
